Articles with "site mutations" as a keyword



Photo from wikipedia

How Single Site Mutations Can Help Understanding Structure Formation of Amyloid β1-40.

Sign Up to like & get
recommendations!
Published in 2023 at "Macromolecular bioscience"

DOI: 10.1002/mabi.202200489

Abstract: Amyloid fibrils represent the structural endpoint on the energetic (mis)folding landscape of very many proteins. Physiologically, amyloid fibrils are observed as a characteristic hallmark in misfolding diseases often associated with degenerative and neurodegenerative disorders. In… read more here.

Keywords: site mutations; structure; help understanding; mutations help ... See more keywords
Photo from wikipedia

Functional analysis of 22 splice-site mutations in the PHEX, the causative gene in X-linked dominant hypophosphatemic rickets.

Sign Up to like & get
recommendations!
Published in 2019 at "Bone"

DOI: 10.1016/j.bone.2019.05.017

Abstract: CONTEXT X-linked hypophosphatemic rickets (XLH) is caused by inactivating mutations in the PHEX gene and is the most common form of hereditary rickets. The splice-site mutations account for 17% of all reported PHEX mutations. The… read more here.

Keywords: splice site; site; site mutations; canonical splice ... See more keywords
Photo from wikipedia

Catalytic Degraders Effectively Address Kinase Site Mutations in EML4-ALK Oncogenic Fusions.

Sign Up to like & get
recommendations!
Published in 2023 at "Journal of medicinal chemistry"

DOI: 10.1021/acs.jmedchem.2c01864

Abstract: Heterobifunctional degraders, known as proteolysis targeting chimeras (PROTACs), theoretically possess a catalytic mode-of-action, yet few studies have either confirmed or exploited this potential advantage of event-driven pharmacology. Degraders of oncogenic EML4-ALK fusions were developed by… read more here.

Keywords: pharmacology; site mutations; catalytic degraders; eml4 alk ... See more keywords
Photo from wikipedia

Abstract 3426: Catalytic degraders effectively address kinase site mutations in EML-ALK oncogenic fusions

Sign Up to like & get
recommendations!
Published in 2023 at "Cancer Research"

DOI: 10.1158/1538-7445.am2023-3426

Abstract: Heterobifunctional degraders, known as proteolysis targeting chimeras (PROTACs), is an emerging modality for drug discovery, and theoretically possess catalytic mode-of-action, yet few studies have either confirmed or exploited this potential advantage of event-driven pharmacology. Degraders… read more here.

Keywords: site mutations; pharmacology; kinase; catalytic degraders ... See more keywords
Photo from wikipedia

The origin and distribution of ‘Kokubu’-type splice-site mutations of the MLO genes in tobacco varieties

Sign Up to like & get
recommendations!
Published in 2022 at "Breeding Science"

DOI: 10.1270/jsbbs.22001

Abstract: The Japanese domestic tobacco (Nicotiana tabacum L.) cultivar ‘Kokubu’ shows high powdery mildew resistance that is controlled by splice-site mutations of two MILDEW LOCUS O genes, NtMLO1 and NtMLO2. We investigated the existence of the… read more here.

Keywords: site mutations; tobacco; mutation; site ... See more keywords
Photo from wikipedia

Novel Missense and Splice Site Mutations in USH2A, CDH23, PCDH15, and ADGRV1 Are Associated With Usher Syndrome in Lebanon

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Genetics"

DOI: 10.3389/fgene.2022.864228

Abstract: The purpose of this study was to expand the mutation spectrum by searching the causative mutations in nine Lebanese families with Usher syndrome (USH) using whole-exome sequencing. The pathogenicity of candidate mutations was first evaluated… read more here.

Keywords: usher syndrome; site mutations; splice site; analysis ... See more keywords

MET Exon 14 Splice-Site Mutations Preferentially Activate KRAS Signaling to Drive Tumourigenesis

Sign Up to like & get
recommendations!
Published in 2022 at "Cancers"

DOI: 10.3390/cancers14061378

Abstract: Simple Summary MET exon 14 splice-site mutations occur in ~3–4% of lung adenocarcinoma cases, defining a cohort of patients which might benefit from anti-MET targeted therapy. Such therapies have yielded mixed results, however, pointing to… read more here.

Keywords: site mutations; exon splice; met ex14; met exon ... See more keywords